Arama Sonuçları - Wu, Alan
- Gösterilen 1 - 20 sonuçlar arası kayıtlar. 149
- Sonraki Sayfaya Git
-
1
Drug metabolizing enzyme activities versus genetic variances for drug of clinical pharmacogenomic relevance Yazar: Wu, Alan HB
Baskı/Yayın Bilgisi 2011Metin -
2
-
3
Biomarkers Beyond the Natriuretic Peptides for Chronic Heart Failure: Galectin-3 and Soluble ST2 Yazar: Wu, Alan H.B.
Baskı/Yayın Bilgisi 2012Metin -
4
Screening the General Population for SARS-CoV-2 Virus and COVID-19 Antibodies: A Counterargument Yazar: Wu, Alan H B
Baskı/Yayın Bilgisi 2020Metin -
5
Urinalysis and stool testing Yazar: Wu, Alan H.B.
Baskı/Yayın Bilgisi 2021Metin -
6
Analytical and clinical concordance of free light chain assay Yazar: Smith, Andrew, Wu, Alan H.B.
Baskı/Yayın Bilgisi 2018Metin -
7
-
8
Chronic alcohol use does not protect against COVID-19 infection Yazar: Lebin, Jacob A., Mudan, Anita, Wu, Alan H.B.
Baskı/Yayın Bilgisi 2021Metin -
9
RNA-Directed DNA Polymerase and Virus-Induced Leukemia in Mice Yazar: Wu, Alan M., Ting, Robert C. Y., Gallo, Robert C.
Baskı/Yayın Bilgisi 1973Metin -
10
-
11
Evaluation of neutralizing antibodies against SARS-CoV-2 variants after infection and vaccination using a multiplexed surrogate virus neutralization test Yazar: Lynch, Kara L, Zhou, Shuxia, Kaul, Ravi, Walker, Roger, Wu, Alan H
Baskı/Yayın Bilgisi 2022Metin -
12
-
13
-
14
-
15
-
16
Reduced Immune Response and Neutralizing Antibody Activity to the SARS-CoV-2 Vaccination in Patients with a History of Solid Organ Transplant Yazar: French, Deborah, Ong, Chui Mei, Patel, Paul, Zuk, Marisa, Wu, Alan H B
Baskı/Yayın Bilgisi 2022Metin -
17
-
18
-
19
A SARS-CoV-2 Label-Free Surrogate Virus Neutralization Test and a Longitudinal Study of Antibody Characteristics in COVID-19 Patients Yazar: Luo, Yiqi Ruben, Yun, Cassandra, Chakraborty, Indrani, Wu, Alan H. B., Lynch, Kara L.
Baskı/Yayın Bilgisi 2021Metin -
20